Alector, Inc. (ALEC) vs Whitehawk Therapeutics, Inc. (WHWK)

Alector, Inc. and Whitehawk Therapeutics, Inc. are both Biotechnology companies. Alector, Inc. and Whitehawk Therapeutics, Inc. are of similar size ($220.1M and $214.4M). Whitehawk Therapeutics, Inc. grew revenue faster over the last twelve months: 16.5% against −82.9%. Whitehawk Therapeutics, Inc. has the higher net margin (0.00% vs −850.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Whitehawk Therapeutics, Inc. leads on 12 and Alector, Inc. on 4.

Valuation

Metric ALEC WHWK Biotechnology median
P/E n/m n/m 7.88
P/S 15.65 11.19 11.47
P/B n/m 1.70 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 4.49 4.39 10.73
Earnings yield (56.41%) (29.87%) (28.84%)
Free cash flow yield (73.03%) (22.49%) (23.03%)

Profitability

Metric ALEC WHWK Biotechnology median
Gross margin 100.00% 88.72% 65.16%
Operating margin (912.40%) 0.00% 0.00%
Net margin (850.13%) 0.00% 0.00%
Free cash flow margin (1,142.55%) 0.00% 0.00%
Return on equity (385.11%) (44.98%) (57.72%)
Return on assets (42.15%) (42.60%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALEC WHWK Biotechnology median
Revenue growth (TTM) (82.91%) 16.51% 5.64%
EPS growth (last fiscal year) (13.01%) 86.02% —
Revenue growth, 5-year CAGR (0.05%) (13.29%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALEC WHWK Biotechnology median
Debt to equity (0.99) 0.00 0.00
Current ratio 5.26 17.38 4.73
Net debt to EBITDA 1.61 1.26 0.96

Dividend

Metric ALEC WHWK Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ALEC WHWK Biotechnology median
Market cap 214.38m 220.05m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack